Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Lloyd Mackenzie | M | 56 |
Symvivo Corp.
 Symvivo Corp. BiotechnologyHealth Technology Symvivo Corp. is a Canadian clinical-stage biotechnology company that specializes in advancing therapeutics in the area of oral DNA vaccines, oncology, immunology, and gene replacement. The private company's Bactrl platform technology delivers plasmid DNA, both orally and through IV application, that enables a patient's own cells to produce therapeutic proteins. Symvivo is headquartered in Burnaby, Canada. The company was founded by Alexander Graves, who has been the CEO since incorporation. | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Sievers | M | 60 |
Symvivo Corp.
Symvivo Corp. BiotechnologyHealth Technology Symvivo Corp. is a Canadian clinical-stage biotechnology company that specializes in advancing therapeutics in the area of oral DNA vaccines, oncology, immunology, and gene replacement. The private company's Bactrl platform technology delivers plasmid DNA, both orally and through IV application, that enables a patient's own cells to produce therapeutic proteins. Symvivo is headquartered in Burnaby, Canada. The company was founded by Alexander Graves, who has been the CEO since incorporation. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 2 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alexander Graves
- Personal Network
